Table 3 Univariate and multivariate analyses of SULT2B1b expression and patients’ survival in the Luoyang cohort (n=202)
Univariate analysis | Multivariate analysisa | ||||||
|---|---|---|---|---|---|---|---|
Variables | Categories | HR | 95% CI | P-value | HR | 95% CI | P-value |
Disease-specific survival | |||||||
Age (years) | ≥60/<60 | 2.049 | 1.208–3.477 | 0.008 | 1.974 | 1.142–3.414 | 0.015 |
Sex | Male/female | 0.756 | 0.498–1.149 | 0.190 | 0.926 | 0.595–1.440 | 0.732 |
Tumor location | Colon/rectum | 1.003 | 0.760–1.322 | 0.985 | 0.915 | 0.683–1.227 | 0.554 |
Tumor size (cm) | ≥5/<5 | 1.076 | 0.703–1.647 | 0.736 | 1.127 | 0.731–1.740 | 0.588 |
Differentiation grade | Poor/well+moderate | 1.419 | 0.907–2.220 | 0.126 | 1.245 | 0.789–1.964 | 0.347 |
TNM stage | III/I+II | 2.895 | 1.895–4.422 | <0.001 | 2.705 | 1.729–4.231 | <0.001 |
SULT2B1b expressionb | High/low | 3.162 | 1.936–5.164 | <0.001 | 2.694 | 1.631–4.451 | <0.001 |
Disease-free survival | |||||||
Age ( years) | ≥60/<60 | 1.373 | 0.899–2.095 | 0.142 | 1.408 | 0.904–2.194 | 0.131 |
Sex | Male/female | 0.783 | 0.539–1.138 | 0.200 | 1.025 | 0.691–1.519 | 0.904 |
Tumor location | Colon/rectum | 0.875 | 0.680–1.124 | 0.295 | 0.883 | 0.675–1.157 | 0.368 |
Tumor size (cm) | ≥5/<5 | 0.948 | 0.651–1.380 | 0.779 | 0.984 | 0.670–1.444 | 0.932 |
Differentiation grade | Poor/well+moderate | 1.380 | 0.922–2.065 | 0.118 | 1.172 | 0.778–1.765 | 0.448 |
TNM stage | III/I+II | 4.555 | 3.071–6.757 | <0.001 | 4.202 | 2.786–6.338 | <0.001 |
SULT2B1b expressionb | High/low | 2.278 | 1.525–3.403 | <0.001 | 1.938 | 1.277–2.941 | 0.002 |